Induction of the oxidative catabolism of retinoic acid in MCF-7 cells

British Journal of Cancer

Volumn 75, Issue 8, 1997, Pages 1098-1104

  Krekels, M D W G ^a   Verhoeven, A ^a   Van Dun, J ^a   Cools, W ^a   Van Hove, C ^a   Dillen, L ^a   Coene, M C ^a   Wouters, W ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Induction; Liarozole fumarate; MCF 7 cells; Oxidative catabolism; Retinoic acid

Indexed keywords

ANTINEOPLASTIC AGENT; DACTINOMYCIN; LIAROZOLE FUMARATE; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN; RETINOIC ACID RECEPTOR; RETINOID; RETINOL;

ARTICLE; CATABOLISM; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG OXIDATION; ENZYME INDUCTION; ENZYME KINETICS; HUMAN; HUMAN CELL; MICHAELIS CONSTANT; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 8044225936     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.190     Document Type: Article

References (61)

1. Allenby G, Bocquel M-T, Saunders M, Kazmer S, Speck J, Rosenberg M, Lovey A, Kastner P, Grippo JF, Chambon P and Levin AA (1993) Retinoic acid receptors and retinoid x receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci USA 90: 30-34
2. Berggren Soderhund M, Johanesson G and Fex G (1995) Expression of human all-trans-retinoic acid receptor beta and its ligand-binding domain in escherichia coli. Biochem J 308: 353-359
3. Bhat PV and Lacroix A (1989) Metabolism of retinol and retinoic acid in N-methyl-N-nitrosourea-induced mammary carcinoma in rats. Cancer Res 49: 139-144
4. Bollag W and Holdener EE (1992) Retonoids in cancer prevention and therapy. Ann Oncol 3: 513-526
5. Brand N, Petkovich M, Krust A, Chambon P, De The M, Marchio A, Tiollais P and Dejean A (1988) Identification of a second human retinoic acid receptor. Nature 332: 850-853
6. Crettaz M, Baron A, Siegenthaler G and Hunziker W (1990) Ligand specifities of recombinant retinoic acid receptors RAR-alpha and RAR-beta. Biochem J 272: 391-397
7. De Coster R, Wouters W, Van Ginckel R, End D, Krekels M, Coene M-C and Bowden C (1992) Experimental studies with liarozole (R 75 251): an antitumoral agent which inhibits retinoic acid breakdown. J Steroid Biochem Molec Biol 43: 197-210
8. Dijkman GA, Van Moorselaar RJA, Van Ginckel R, Van Stratum P, Wouters L, Debruyne FMJ, Schalken JA and De Coster R (1994) Antitumoral effects of liarozole in androgen-dependent and independent R3327-Dunning prostate adenocarcinomas. J Urol 151: 217-222
9. Duell E, Astrom A, Griffiths CEM, Chambon P and Voorhees JJ (1992) Human skin levels of retinoic acid and cytochrome P450-derived 4-hydroxy retinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid-receptor-mediated transcription in vitro. J Clin Invest 90: 1269-1274
10. Elder JT, Cromie MA, Griffiths CEM, Chambon P and Voorhees JJ (1993) Stimulus-selective induction of CRABP II mRNA: a marker for retinoic acid action in human skin. J Invest Dermatol 100: 356-359
11. Fiorella PD and Napoli JL (1991) Expression of cellular retinoic acid binding protein (CRABP) in escherichia coli. Characterization and evidence that holo-CRABP is a substrate in retinoic acid metabolism. J Biol Chem 266: 16572-16579
12. Frolik CA, Roberts AB, Tavela TE, Roller PP, Newton DL and Sporn MB (1979) Isolation and identification of 4-hydroxy and 4-oxoretinoic acid. In vitro metabolites of all-trans-retinoic acid in hamster trachea and liver. Biochemistry 18: 2092-2097
13. Frolik CA, Roller PP, Roberts AB and Sporn MB (1980) In vitro and in vivo metabolism of all-trans- and 13-cis-retinoic acid in hamsters. J Biol Chem 255: 8057-8062
14. 3H]-retinoic acid in cell cultures. Pharmacol Toxicol Methods 34: 219-223
15. Giguere V, Ong ES, Segui P and Evans RM (1987) Identification of a receptor for the morphogen retinoic acid. Nature 330: 624-629
16. Han IS and Choi J-H (1996) Highly specific cytochrome P450-like enzymes for all-trans-retinoic acid in T47D human breast cancer cells. J Clin Endocrinol Metab 81: 2069-2075
17. Hanni R and Bigler F (1977) Isolation and identification of three major metabolies of retinoic acid from rat feces. Helv Chim Acta 60: 881-887
18. Hanni R, Bigler F, Meister W and Englert G (1976) Isolation and identification of three urinary metabolites of retinoic acid in the rat. Helv Chim Acta 59: 2221-2227
19. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichelle G, Evans RM and Thaller C (1992) 9-cis-retinoic acid is a high affinity ligand for the retinoid x receptor. Cell 68: 397-406
20. Ho CK (1985) Synergislic anticellular effect of a combination of β-interferon and retinoic acid against U937 cells. Cancer Res 45: 5348-5351
21. Jetten AM, Anderson K, Deas MA, Kagechika H, Lotan R, Rearick JI and Shudo K (1987) New benzoic acid derivatives with with retinoid activity: lack of direct correlation between biological activity and binding to cellular retinoic acid binding protein. Cancer Res 47: 3523-3527
22. Jones-Villeneuve EMV, McBurney MW, Rogers KA and Kalnins VI (1982) Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J Cell Biol 94: 253-262
23. Kraft JC, Slikker W, Bailey JR, Roberts LG, Fisher B, Wittfout W and Nau H (1991) Plasma pharmacokinetics and metabolism of β-cis and all-trans-retinoic acid in the cynomolgus monkey and the identification of β-cis and all-trans-retinoic-β-glucuronides. Drug Metab Dispos 19: 317-324
24. Krekels MDWG, Zimmerman J, Janssens B, Van Ginckel R, Van Hove C, Coene M-C and Wouters W (1995) Analysis of the oxidative catabolism of retinoic acid in rat Dunning R3327G prostate tumors. Prostate 29: 35-41
25. Krust A, Kastner P, Petkovich M, Zelent A and Chambon P (1989) A third human retinoic acid receptor: μ RAR gamma. Proc Natl Acad Sci USA 86: 5310-5314
26. Lampron C, Rochette-Egly C, Gorry P, Dolle P, Mark M, Lufkin T, Lemeur M and Chambon P (1995) Mice deficient in cellular retinoic acid binding protein II (CRABP II) or in both CRABP I and CRABP II are essentially normal. Development 121: 539-548
27. Leid M, Kastner P and Chambon P (1992) Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci 17: 427-433
28. Leo MA and Lieber CS (1985) New pathway for retinol metabolism in liver microsomes. J Biol Chem 260: 5228-5231
29. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Husellon C, Allenby G, Speck J, Kratzeneisen C, Rosenberg M, Lovey A and Grippo JF (1992) 9-cis retinoic acid stereoisomer hinds and activates the nuclear receptor R×R alpha. Nature 355: 359-361
30. Lotan R and Lotan D (1981) Stimulation of melanogenesis in a human melanoma cell line by retinoids. Cancer Res 40: 3345-3350
31. Mahler G, Verhelst J and Denis L (1993) Ketoconazole and liarozole in the treatment of advanced prostatic cancer. Cancer Suppl 71: 1068-1073
32. Mangelsdorf DJ, Ong ES, Dyck JA and Evans RM (1990) Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345: 224-229
33. Mangelsdorf DJ, Borgmeyer U, Heymans RA, Zhou JY, Ong ES, Oro AE, Kahizuka A and Evans RM (1992) Characterization of three R×R genes that mediate the action of 9-cis-retinoic acid. Genes Dev 6: 329-344
34. Matsushima Y, Kawachi E, Tanaka H, Kagechika H, Hashimoto N and Shudo K (1992) Differentiation inducing activity of retinoic acid isomers and their oxidized analogues on human promyelocytic leukemia HL-60 cells. Biochem Biophys Res Commun 189: 1136-1142
35. McCormick AM and Napoli JL (1982) Identification of 5,6-expoxy retinoic acid as an endogenous retinol metabolite. J Biol Chem 257: 1730-1735
36. Miller VA, Rigas JR, Muindi JRF, Tong WP, Venkatraman H, Kris MG and Warrell P (1994) Modulation of all-trans-retinoic acid pharmacokinetics by liarozole. Cancer Chemother Pharmacol 34: 522-526
37. Muindi J, Frankel JR, Miller WH, Jakubowski A, Scheinberg DA, Young CW, Dmitrowsky E and Warrell RP (1992) Continuous treatment with all-trans-retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid 'resistance' in patients with acute promyelocytic leukemia. Blood 79: 299-303
38. Napoli JL (1986) Retinol metabolism in LCC-PK1 cells. J Biol Chem 261: 13592-13597
39. Napoli JL (1993) Biosynthesis and metabolism of retinoic acid: roles of CRBP and CRABP in retinoic acid homeostasis. J Nutr 123: 362-366
40. Ong DE and Chytil F (1983) Vitamin A and cancer. Vitamin Horm 40: 105-144
41. Parkinson DR, Smith MA, Cheson BD, Stevenson MC and Friedmans MA (1992) Trans-retinoic acid and differentiation agents. Semin Oncol 19: 734-741
42. Petkovich M, Brand NJ, Krust A and Chambon P (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330: 444-450
43. Ramp U, Gerharz CD, Eiller E, Busalski HK and Gabbert HE (1994) Effects of retinoic acid metabolites on proliferation and differentiation on the clonal rhabdomyosarcoma cell line BA-HAN-IC. Biol Cell 81: 31-37
44. Repa JJ, Hanson KK and Clagett-Dame M (1993) All-trans-retinol is a ligand for the retinoic acid receptors. Proc Natl Acad Sci USA 90: 7239-7297
45. Roberts AB, Lamb LC and Sporn MB (1980) Metabolism of all-trans-retinoic acid in hamster liver microsomes. Oxidation of 4-hydroxy to 4-keto-retinoic acid. Arch Biochem Biophys 199: 374-383
46. Sani BP, Singh RK, Reddy LG and Gaub M-P (1990) Isolation, partial purification and characterization of nuclear retinoic acid receptor from chick skin. Arch Biochem Biophys 283: 107-113
47. Sietsema WK and De Luca HF (1982) Retinoic acid 5,6-epoxidase. J Biol Chem 257: 4265-4270
48. Smets G, Van Ginckel R, Daneels G, Moeremans M, Van Wauwe J, Coene M-C, Ramaekers FCS, Schalken JA, Borgers M and De Coster R (1995) Liarozole. an antitumor drug, modulates cytokeratin expression in the Dunning AT-6sq prostatic carcinoma through in situ accumulation of all-trans-retinoic acid. The Prostate 27: 129-140.
49. Sporn M and Roberts AB (1983) Role of retinoids in differentiation and carcinogenesis. Cancer Res 43: 3034-3040
50. Strickland S and Mahdavi V (1978) The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15: 393-403
51. Vanden Bossche H and Willemsens G (1990) Retinoic acid and cytochrome P450. In Retinoids: 10 years on, Saurat JH (ed.), pp. 79-88. Karger: Basle
52. Van Wauwe JP, Coene M-C, Goossens J, Van Nyen G, Cools W and Lauwers W (1988) Ketoconazole inhibits the in vitro and in vivo metabolism of all-trans-retinoic acid. J Pharmacol Exp Ther 245: 718-722
53. Van Wauwe JP, Coene M-C, Goossens J and Monbaliu J (1990) Effects of cytochrome P450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats. J Pharmacol Exp Ther 252: 365-369
54. Van Wauwe JP, Van Nyen G, Coene M-C, Stoppie P, Cools W, Goossens G, Borghgraef P and Janssen PAJ (1992) Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo. J Pharmacol Exp Ther 261: 773-779
55. Van Wauwe JP, Coene M-C, Cools W, Goossens J, Lauwers W, Le Jeune L, Van Hove C and Van Nyen G (1994) Liarozole-fumarate inhibits the metabolism of 4-keto-all-trans-retinoic acid. Biochem Pharmacol 47: 737-741
56. Varani J, Gendimenico GA, Shah B, Gibbs D, Capetola RJ, Mezick JA and Voorhees JJ (1991) A direct comparison of pharmacologic effects of retinoids on skin cells in vitro and in vivo. Skin Pharmacol 4: 254-261
57. Williams JB and Napoli JL (1985) Metabolism of retinoic acid and retinol during differentiation of F9 embryonal carcinoma cells. Proc Natl Acad Sci USA 82: 4658-4662
58. Williams JB and Napoli JL (1987) Inhibition of retinoic acid metabolism by imidazole antimyotics in F9 embryonal carcinoma cells. Biochem Pharmacol 36: 1386-1388
59. Williams JB, Smilds CO, Brettel LM and Napoli JL (1987) Assessment of retinoid-induced differentiation of F9 embryonal carcinoma cells with an enzyme-linked immunosorbent assay for laminin; statistical comparison of dose-response curves. Anal Biochem 160: 267-274
60. Wolf G (1984) Multiple functions of vitamin A. Physiol Rev 64: 873-937
61. Wouters W, Van Dun J, Dillen A, Coene M-C, Cools W and De Coster R (1992) Effects of liarozole, a new antitumoral compound, on retinoic acid induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 breast cancer cells. Cancer Res 52: 2841-2846